Rana Mckay, Md
Clinical trials sponsored by Rana Mckay, Md, explained in plain language.
-
New drug combo aims to stall Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study tests whether combining two drugs, cabozantinib and nivolumab, can slow the growth of advanced prostate cancer that has stopped responding to hormone therapy. About 47 men with metastatic castration-resistant prostate cancer will receive the combination. The main goal …
Phase: PHASE2 • Sponsor: Rana McKay, MD • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
New combo aims to shrink prostate tumors before surgery
Disease control Recruiting nowThis study tests whether giving a targeted drug (olaparib) plus hormone therapy for 6 months before prostate removal can eliminate or shrink tumors in men with aggressive prostate cancer. Participants must have specific gene changes (HRR alterations). After surgery, doctors will …
Phase: PHASE2 • Sponsor: Rana McKay, MD • Aim: Disease control
Last updated May 17, 2026 02:02 UTC